Research Article
Treatment of Acute Nonvariceal Upper Gastrointestinal Bleeding in Chinese Patients on Antithrombotic Therapy
Table 1
Demographic and clinical data of patients with upper gastrointestinal bleeding.
| | Item | Antithrombotic group | Control group | Chi-squared or Fisher’s exact test or Mann–Whitney test | | | value |
| | Age (median [IQR], y) | 67.0 (18.0) | 58.0 (30.0) | | | | Sex, M/F () | 71/28 | 105/26 | | | | Forrest classification, high risk/low risk () | 78/21 | 84/47 | | | | Bleeding sites, E/S/D () | 12/26/61 | 6/52/73 | | | | Esophageal bleeding (, %) | 12 (12.1) | 6 (4.6) | | | | Endoscopy with anesthesia under tracheal intubation (, %) | 20 (20.2) | 1 (0.7) | | | | PPI therapy prior the bleeding (, %) | 43 (43.4) | 11 (8.4) | | | | Interventional therapy (, %) | 8/90 | 2/129 | | | | APT/ACT () | 80/19 | — | — | — | | PCI or />1 m () | 16/64 | — | — | — | | />1 m () | 5/14 | — | — | — |
|
|
IQR: interquartile range; E: esophagus; S: stomach; D: duodenum; APT: antiplatelet therapy; ACT: anticoagulant therapy; PCI: percutaneous coronary intervention; CAB: coronary artery bypass graft.
|
